Anzeige
Mehr »
Login
Freitag, 08.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
4.000 Meilen, um herauszufinden, warum der „Warren Buffett des Bergbaus" in diese Kupferaktie investierte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
453 Leser
Artikel bewerten:
(2)

Form 8 - Daily Mail and General Trust plc

DJ Form 8 - Daily Mail and General Trust plc

Daily Mail and General Trust plc (DMGT) 
Form 8 - Daily Mail and General Trust plc 
23-Jul-2021 / 15:19 GMT/BST 
Dissemination of a Regulatory Announcement, transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
FORM 8 (OPD) 
 
PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER 
Rules 8.1 and 8.2 of the Takeover Code (the "Code") 
 
1. KEY INFORMATION 
 
(a) Full name of discloser:                                Daily Mail and General Trust 
                                              plc ("DMGT") 
(b) Owner or controller of interests and short positions disclosed, if different from 1 
(a): 
                                              n/a 
 The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), 
settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:  Daily Mail and General Trust 
                                              plc 
 Use a separate form for each offeror/offeree 
(d) Is the discloser the offeror or the offeree?                      OFFEREE 
(e) Date position held: 
                                              22 July 2021 
 The latest practicable date prior to the disclosure 
(f) In addition to the company in 1(c) above, is the discloser making disclosures in 
respect of any other party to the offer?                          n/a 
 If it is a cash offer or possible cash offer, state "N/A" 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Class of relevant security: 
                                          DMGT 12.5p (non-voting) A Ordinary 
 
                                          Interests     Short positions 
                                          Number   %   Number  % 
(1) Relevant securities owned and/or controlled:                  Nil 
                                                Nil  Nil    Nil 
 
(2) Cash-settled derivatives: 
                                          Nil     Nil  Nil    Nil 
 
(3) Stock-settled derivatives (including options) and agreements to purchase/sell: Nil     Nil  Nil    Nil 
 TOTAL:                                      Nil     Nil  Nil    Nil 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b) Rights to subscribe for new securities

Class of relevant security in relation to which subscription right exists: None 
Details, including nature of the rights concerned and relevant percentages: None 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of 
any person acting in concert with the party to the offer making the disclosure: 
 
 1. Interests in relevant securities of DMGT held by DMGT directors and their close relatives and related trusts: 
 
 
               Interest 
Director name 
 
               Lord Rothermere holds a total 26.40 per cent. interest in DMGT A Ordinary shares, as 
               follows: 
 
                1. Beneficial ownership of 610,375 A Ordinary shares in DMGT. The registered owner of 
                 the shares is UBS Private Banking Nominees Limited. 
 
                2. UBS Private Banking Nominees Limited is the registered owner of 204,221 A Ordinary 
                 shares in DMGT. The beneficial owners of these shares are David Nelson (a director of 
                 DMGT) and Lady Claudia Rothermere (Lord Rothermere's wife) in their capacity as 
                 trustees of the WM Trust. The shares are held for the benefit of Lord Rothermere and 
                 members of his close family. 
 
                3. UBS Private Banking Nominees is the registered owner of 4,687,424 A Ordinary shares 
                 in DMGT. The beneficial owners of these shares are Lord Rothermere, Lady Rothermere 
                 and Vyvyan Harmsworth in their capacity as trustees of the Rothermere Foundation. The 
The Right Honourable Jonathan   Rothermere Foundation benefits charitable purposes. 
Harold Esmond Vere Viscount 
Rothermere ("Lord Rothermere 
") 
                4. SIX SIS Ltd is the registered owner of 63,569 A Ordinary shares in DMGT. Ortalide 
                 Investments Limited is the beneficial owner of the shares. Ortalide Investments 
                 Limited is a company owned by a related trust - the Rothermere 1985 Bermudian 
                 Declaration (The Hon Geraldine Harmsworth Maxwell Fund) - the beneficiaries of which 
                 are Lord Rothermere's sister, Geraldine Harmsworth Maxwell, and her children. 
 
               Lord Rothermere is also a director of RCL, which is: 
 
                - The beneficial owner of 58,207,016 (27.61 per cent.) A Ordinary shares in DMGT. UBS 
                 Private Banking Nominees Limited is the registered owner of 58,136,959 of the shares. 
                 Wealth Nominees is the registered owner of the remaining 70,057 shares, which are 
                 held by 1991 Harmsworth Declaration (Main Fund) as nominee for RCL; and 
 
                - The beneficial owner of 19,890,364 (100 per cent.) Ordinary Shares in DMGT. RCL is 
                 the registered owner of 17,390,364 of these shares. Harmsworth Trust Company (PTC) 
                 Limited is the registered owner of the remaining 2,500,000 shares. 
               Paul Zwillenberg holds a total 0.24 per cent. interest in A Ordinary Shares in DMGT, as 
               follows: 
                - The beneficial and registered owner of 506,437 A Ordinary shares in DMGT. 
Paul Zwillenberg 
                - The beneficial owner of 1,037 A Ordinary Shares in DMGT. The registered owner of the 
                 shares is Equiniti Share Plan Trustees Limited. 
 
               Kevin Beatty holds a total 0.29 per cent. interest in A Ordinary Shares in DMGT, as 
               follows: 
 
                - The beneficial owner of 607,086 A Ordinary Shares in DMGT. The registered owner of 
Kevin Beatty           the shares is JM Finn Limited. 
 
                - The beneficial owner of 2,204 A Ordinary Shares in DMGT. The registered owner of the 
                 shares is Equiniti Share Plan Trustees Limited. 
 
               Kevin Parry holds a total 0.01 per cent. interest in A Ordinary Shares in DMGT, as 
               follows: 
 
                - The beneficial owner of 2,760 A Ordinary Shares in DMGT. The registered owner of the 
Kevin Parry            shares is CGWL Nominees Limited. 
 
                - The beneficial owner of 9,805 A Ordinary Shares in DMGT. The registered owner of the 
                 shares is Barclays Nominees Limited. 
 
               Timothy Collier is the beneficial owner of 439,668 (0.21 per cent.) A Ordinary shares in 
               DMGT. The registered owner of the shares is Equiniti Global Nominees. 
Timothy Collier 
 
 
               UBS Private Banking Nominees Limited is the registered owner of 204,221 (0.1 per cent.) A 
               Ordinary shares in DMGT which are beneficially owned by David Nelson and Lady Claudia 
               Rothermere (Lord Rothermere's wife) in their capacity as trustees of the WM Trust. The 
David Nelson         shares are held for the benefit of Lord Rothermere and the members of his close family. 
 
 
               François Morin is not personally interested in any relevant securities of DMGT. However, 
               he is a director of RCL, which is: 
 
                - The beneficial owner of 58,207,016 (27.61 per cent.) A Ordinary shares in DMGT. UBS 
                 Private Banking Nominees Limited is the registered owner of 58,136,959 of the shares. 
                 Wealth Nominees is the registered owner of the remaining 70,057 shares, which are 

(MORE TO FOLLOW) Dow Jones Newswires

July 23, 2021 10:19 ET (14:19 GMT)

© 2021 Dow Jones News
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.